|
Which patients are suitable for Symbicort SMART®?
|
| |
| Which patients are suitable for Symbicort SMART®? |
| Symbicort SMART® is suitable for adult asthma patients who are eligible for ICS/LABA (combination) therapy. |
| |
| Note: This is based on the EU SmPc. Labels vary across different countries in the world. Please see national prescribing information for further information regarding dosing instructions. |
| |
| |
| What do the global asthma guidelines say about Symbicort SMART®? |
This new asthma management approach has been recognised in the 2006 Global Initiative for Asthma (GINA) guidelines as an effective management approach for reducing exacerbations in asthma patients suitable for combination therapy (Global Initiative for Asthma 2006). The guidelines state,
"Combination inhalers containing formoterol and budesonide may be used for both rescue and maintenance. Both components of budesonide-formoterol given as-needed contribute to enhanced protection from severe exacerbations in patients receiving combination therapy for maintenance and provide improvements in asthma control at relatively low doses of treatment” and, “The benefit in preventing exacerbations appears to be the consequence of early intervention at a very early stage of a threatened exacerbation."
|
| |
back to top 
|
